EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of haematopoietic progenitors in vitro

Paolo Petazzi, Telma Ventura iD, Francesca Paola Luongo iD, Heather McClafferty, Alisha May iD, Helen Alice Taylor, Michael J Shipston iD, Nicola Romanò iD, Lesley M Forrester, Pablo Menendez iD, Antonella Fidanza iD

eLife · 2024

DOI: 10.7554/elife.94884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Paolo Petazzi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Josep Carreras Leukemia Research Institute, Barcelona, Spain. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 2, Cell Differentiation, Hematopoietic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, European Hematology Association, American Society for Hematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major challenge in the stem cell biology field is the ability to produce fully functional cells from induced pluripotent stem cells (iPSCs) that are a valuable resource for cell therapy, drug screening, and disease modelling. Here, we developed a novel inducible CRISPR-mediated activation strategy (iCRISPRa) to drive the expression of multiple endogenous transcription factors (TFs) important for in vitro cell fate and differentiation of iPSCs to haematopoietic progenitor cells. This work has identified a key role for IGFBP2 in developing haematopoietic progenitors. We first identified nine candidate TFs that we predicted to be involved in blood cell emergence during development, then generated tagged gRNAs directed to the transcriptional start site of these TFs that could also be detected during single-cell RNA sequencing (scRNAseq). iCRISPRa activation of these endogenous TFs resulted in a significant expansion of arterial-fated endothelial cells expressing high levels of IGFBP2, and our analysis indicated that IGFBP2 is involved in the remodelling of metabolic activity during in vitro endothelial to haematopoietic transition. As well as providing fundamental new insights into the mechanisms of haematopoietic differentiation, the broader applicability of iCRISPRa provides a valuable tool for studying dynamic processes in development and for recapitulating abnormal phenotypes characterised by ectopic activation of specific endogenous gene expression in a wide range of systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor Binding Protein 2Cell DifferentiationHematopoietic Stem CellsHumansInduced Pluripotent Stem CellsTranscriptional ActivationCRISPR-Cas SystemsTranscription FactorsPluripotent Stem Cells

Stichwörter der Autor:innen

CRISPR activationdevelopmental biologyhaematopoiesishumanpluripotent stem cellsregenerative medicinestem cells

Substanzen

Insulin-Like Growth Factor Binding Protein 2IGFBP2 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Josep Carreras Leukemia Research Institute, Barcelona, Spain.
  • Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom.
  • Centre for Discovery Brain Sciences, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.
  • Zhejiang University-University of Edinburgh Joint Institute, Zhejiang University School of Medicine, Zhejiang University, Haining, China.
  • CIBER-ONC, ISCIII, Barcelona, Spain.
  • Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

ORCID-Profile: Telma Ventura, Francesca Paola Luongo, Alisha May, Michael J Shipston, Nicola Romanò, Pablo Menendez, Antonella Fidanza

Förderung

  • Biotechnology and Biological Sciences Research Council
  • European Hematology Association
  • American Society for Hematology
  • Medical Research Council
  • College of Medicine and Veterinary Medicine, University of Edinburgh
  • Erasmus +
  • Catalan Government
  • MINECO

Zitieren

APA

Petazzi, P., Ventura, T., Luongo, F. P., McClafferty, H., May, A., Taylor, H. A., Shipston, M. J., Romanò, N., Forrester, L. M., Menendez, P., & Fidanza, A. (2024). A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of haematopoietic progenitors in vitro. eLife. https://doi.org/10.7554/elife.94884

Vancouver

Petazzi P, Ventura T, Luongo FP, McClafferty H, May A, Taylor HA, et al. A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of haematopoietic progenitors in vitro. eLife. 2024. doi:10.7554/elife.94884

BibTeX
@article{Petazzi2024,
  author = {Petazzi, Paolo and Ventura, Telma and Luongo, Francesca Paola and McClafferty, Heather and May, Alisha and Taylor, Helen Alice and Shipston, Michael J and Romanò, Nicola and Forrester, Lesley M and Menendez, Pablo and Fidanza, Antonella},
  title = {A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of haematopoietic progenitors in vitro},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.94884}
}
Kostenlos starten →